new test impact number
launch second test friday new test rapid turnaround
minut point-of care-test poc could huge help caregiv patient
battl plan new poc test avail per day
april build per month earli april abt two test
abl make test per month earli april given price point
two test could gener per month per quarter
test level per month math help off-set potenti
materi declin abt quarterli diagnost busi impact
basic test abt test also cannib test run
system even benefit new test model abt total diagnost
busi better posit devic compani
given test capabl pedialyt use think
conserv assumpt lower total compani ep
estim reduct number new
estim trade
id molecular point care unit place mostli us
test per hour per system rate limit factor today test
suppli abt abil manufactur test system field mention
point care test avail per month earli april
sell test also run test
lab-bas system expect per week
per month earli april allow produc total test per
month system test per test test per
test light convers weekend leverag
expertis bofa life scienc diagnost tool team confid
assumpt reason
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
lead diversifi global
healthcar compani develop manufactur
market brand gener medic devic
nutrit product diagnost solut
expect continu grow underli
earn double-digit rang
grow organ mid high singl digit
rang think given growth profil
least trade line higher multipl
med-tech peer
po base price-to-earnings multipl premium peer
believ justifi base long term growth prospect potenti upsid
organ pipelin new product
downsid risk po lower-than-expect growth emerg market
increas competit pressur profit margin lighter-than-expect
healthcar util price pressur inabl close success integr
deal unfavor fx move greater expect impact
bob hopkin herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
becton dickinson compani
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
